Lianne Kok

Lianne Kok

Auto-generated profile, based on publicly available information

Lianne Kok

Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
LKLianne Kok
Lianne Kok
DMDavid Masopust
David Masopust
TSTon N. Schumacher
Ton N. Schumacher

1 December 2015 in Cell
Verified
Journal Article
Closed access
LPLeïla Perié
Leïla Perié
KDKen R. Duffy
Ken R. Duffy
LKLianne Kok
Lianne Kok
RBRob De Boer
Rob De Boer
TSTon N. Schumacher
Ton N. Schumacher

29 July 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LKLianne Kok
Lianne Kok
FDFeline E. Dijkgraaf
Feline E. Dijkgraaf
JUJos Urbanus
Jos Urbanus
KBKaspar Bresser
Kaspar Bresser
DVDavid W. Vredevoogd
David W. Vredevoogd
TSTon N. Schumacher
Ton N. Schumacher
An increasing body of evidence emphasizes the role of tissue-resident memory T cells (TRM) in the defense against recurring pathogens and malignant neoplasms. However, little is known with regard to the origin of these cells and their kinship to other CD8+ T cell compartments. To address this issue, we followed the antigen-specific progeny of individual naive CD8+ T cells to the T effector (TEFF), T circulating memory (TCIRCM), and TRM pools by lineage-tracing and single-cell transcriptome analysis. We demonstrate that a subset of T cell clones possesses a heightened capacity to form TRM, and that enriched expression of TRM–fate-associated genes is already apparent in the circulating TEFF offspring of such clones. In addition, we demonstrate that the capacity to generate TRM is permanently imprinted at the clonal level, before skin entry. Collectively, these data provide compelling evidence for early stage TRM fate decisions and the existence of committed TRM precursor cells in the circulatory TEFF compartment.

7 April 2022 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
KBKaspar Bresser
Kaspar Bresser
LKLianne Kok
Lianne Kok
ASArpit C. Swain
Arpit C. Swain
LKLisa A. King
Lisa A. King
LJLaura Jacobs
Laura Jacobs
TSTon N. Schumacher
Ton N. Schumacher

1 December 2014 in The Journal of Immunology
Verified
Journal Article
Closed access
MTMachteld M Tiemessen
Machteld M Tiemessen
MBMiranda R M Baert
Miranda R M Baert
LKLianne Kok
Lianne Kok
MEMarja C J A van Eggermond
Marja C J A van Eggermond
PEPeter J van Den Elsen
Peter J van Den Elsen
Frank STAALFrank STAAL
Frank STAAL
The Wnt-responsive transcription factor T cell factor 1 (Tcf1) is well known for its role in thymic T cell development and the formation of memory CD8+ T cells. However, its role in the initial phases of CD8+ T effector cell formation has remained unexplored. We report that high levels of Wnt signaling and Tcf1 are operational in naive and memory CD8+ T cells, whereas Wnt signaling and Tcf1 were low in effector CD8+ T cells. CD8+ T cells deficient in Tcf1 produce IFN-γ more rapidly, coinciding with increased demethylation of the IFN-γ enhancer and higher expression of the transcription factors Tbet and Blimp1. Moreover, virus-specific Tcf1−/− CD8+ T cells show accelerated expansion in acute infection, which is associated with increased IFN-γ and TNF production and lower viral load. Genetic complementation experiments with various Tcf1 isoforms indicate that Tcf1 dosage and protein stability are critical in suppressing IFN-γ production. Isoforms lacking the β-catenin binding domain are equally effective in inhibiting CD8+ effector T cell formation. Thus, Tcf1 functions as a repressor of CD8+ effector T cell formation in a β-catenin/Wnt-independent manner.

1 April 2014 in Trends in Immunology
Verified
Journal Article
Closed access
JRJan C. Rohr
Jan C. Rohr
CGCarmen Gerlach
Carmen Gerlach
LKLianne Kok
Lianne Kok
TSTon N. Schumacher
Ton N. Schumacher